Sprout Health Cost 2026: Tirzepatide, Plans, and Refund Terms

Quick answer: How much does Sprout Health cost?

Sprout Health does not display one universal price across every GLP-1 page.

As of August 8, 2026, its main GLP-1 FAQ showed these standard monthly figures:

• Compounded semaglutide: $299 per month.
• Compounded tirzepatide: $349 per month.

Separate current pages show lower starting or promotional figures. Sprout’s homepage displays compounded semaglutide starting at $149 per month and compounded tirzepatide starting at $199 per month. The dedicated tirzepatide page says starting at $349 and now from $199. Three-month pages displayed:

• Compounded semaglutide: $615 list price for three months, promoted from $465.
• Compounded tirzepatide: $750 list price for three months, promoted from $600.

These are provider-advertised figures, not personalized quotes. The $199 tirzepatide number should be treated as a starting or promotional presentation because Sprout’s main GLP-1 FAQ still lists $349 per month. The medication, formulation, plan length, amount charged today, recurring price, state availability, and clinical eligibility must be confirmed at checkout.

Check Sprout Health’s Current Prices and Terms

· Read the full Sprout Health review

Affiliate disclosure: Care Path Compare may receive compensation if you use a Sprout Health link and make a purchase, at no extra cost to you. Compensation does not determine our editorial conclusions.

Sprout Health pricing at a glance

The lowest advertised amount should not be treated as the permanent monthly price. Sprout’s funnels can differ by medication, promotion, plan length, and landing page.

How much is Sprout Health tirzepatide?

Sprout currently publishes more than one tirzepatide price presentation. The main GLP-1 FAQ lists $349 per month for compounded tirzepatide and advertises $50 off the first month. The homepage separately shows compounded tirzepatide starting at $199 per month, while the dedicated tirzepatide page says starting at $349 and now from $199.

Because those public funnels differ, Care Path Compare does not treat $199 as the verified universal monthly renewal price. Before paying, confirm the exact formulation, amount charged today, ongoing renewal amount, billing cadence, cancellation cutoff, and refund terms. A prescription is not guaranteed, and compounded tirzepatide is not FDA-approved.

Why Sprout Health prices differ across pages

Sprout uses several active marketing and checkout funnels. Some emphasize a standard month-to-month price, while others advertise a lower starting price, discounted first month, or three-month package. The current tirzepatide pages illustrate the issue directly: one main FAQ states $349 per month, while the homepage and dedicated tirzepatide page surface $199 starting or promotional language.

Those presentations are not always synchronized. A consumer may see:

• A standard recurring monthly amount.
• A first-month discount.
• A three-month promotional total.
• A monthly or quarterly rebill schedule.
• Different refund descriptions depending on the page.

The safest comparison is the written checkout confirmation, not the lowest headline. Before paying, save the screen that states:

1. The exact amount charged immediately.
2. The medication and formulation attached to that charge.
3. Whether the plan is monthly or quarterly.
4. The standard renewal amount and next billing date.
5. How many medication shipments are included.
6. The cancellation deadline and refund cutoff.

Compounded semaglutide pricing

Sprout’s main GLP-1 page presented compounded semaglutide at $299 per month. A separate three-month page showed a $615 list price and a promotional amount from $465 for a three-month supply.

The three-month promotion equals $155 per month when divided evenly, but that arithmetic does not establish the payment schedule, renewal price, or exact shipment cadence. Sprout’s How It Works page says quarterly GLP-1 plans may involve medication for a two-month period followed by another medical questionnaire after the third dose of the second month. Consumers should confirm exactly what the three-month charge purchases and when the next charge occurs.

Compounded semaglutide is not FDA-approved. It should not be described as a generic or equivalent version of Wegovy.

Compounded tirzepatide pricing

Sprout’s main GLP-1 FAQ currently presents compounded tirzepatide at $349 per month and advertises $50 off the first month. Its homepage separately shows compounded tirzepatide starting at $199 per month, and the dedicated tirzepatide page says starting at $349 and now from $199. A separate three-month page shows a $750 list price and a promotional amount from $600.

The $199 figure is therefore best treated as a starting or promotional price rather than a verified universal ongoing rate. Likewise, the $600 three-month total equals $200 per month when divided evenly, but that arithmetic does not prove monthly billing. Verify the amount charged, formulation, number of shipments, refill requirements, renewal date, and post-promotion price.

Compounded tirzepatide is not FDA-approved and should not be described as a generic, equivalent, or clinically interchangeable version of Zepbound.

What the advertised price appears to include

Sprout’s current compounded-program pages describe the price as including:

• Medication when prescribed.
• Review by an independent licensed clinician.
• Follow-up appointments and clinician messaging.
• Ongoing clinical oversight.
• Automatic refill processing unless paused or canceled.
• Home delivery or shipping.
• Customer support.

Some pages say there are no separate membership or consultation charges. Laboratory requirements and laboratory costs are not clearly disclosed across the pages reviewed, so consumers should ask whether testing is required and who pays for it.

Does the price increase when the dose changes?

Current promotional pages say the agreed recurring medication-and-care price does not increase solely because the clinician changes the dose. That statement should be confirmed in the final checkout terms because the applicable product, promotion, and recurring amount may differ by funnel.

A stable advertised price does not guarantee that a dose increase will occur. Dose selection and changes are clinical decisions made by the prescribing professional.

Monthly billing and automatic renewal

Sprout’s How It Works page says monthly plans are rebilled on the same date each month. After rebilling, the member receives another medical questionnaire. A clinician reviews the refill information and decides whether another prescription is appropriate before the next shipment.

The page also says the charge amount, frequency, and billing date are shown at checkout. Automatic renewal means a future charge may occur unless the plan is canceled before the relevant rebill or processing cutoff.

Three-month and quarterly billing

Sprout also describes quarterly subscription plans that rebill every three months. The public instructions say GLP-1 quarterly fulfillment may differ from a simple three-month shipment: medication may be supplied for two months, followed by another medical questionnaire before continued fulfillment.

Before choosing a three-month offer, ask:

• Is the full promotional amount charged upfront?
• How many shipments will arrive?
• Does the package contain two or three months of medication?
• Is another clinician review required before the final portion?
• What is the next quarterly renewal amount?
• Can an unshipped portion be refunded?

Cancellation timing

Sprout’s current marketing pages generally say plans can be canceled through the portal before the next shipment, refill, or prescription is processed. The public pages do not present one consistently worded cutoff across every funnel.

Because the cutoff descriptions vary, do not rely on “cancel anytime” without checking the checkout terms tied to the specific plan. Cancel before the next refill or shipment is processed and obtain written confirmation that the next charge and shipment were stopped.

Canceling future service and receiving a refund for an existing charge are separate questions.

Refund rules are not presented consistently

Sprout’s pages describe several refund stages, but the wording differs by funnel and policy version.

The current formal Refund and Returns Policy states that prescription medications cannot be returned and that all prescription medications are non-refundable. It separately describes a 48-hour reporting window for damaged, lost, or unreceived medication and says Sprout may apply a credit for a replacement order after review.

Marketing pages use different pre-fulfillment summaries. The main GLP-1 FAQ says a full refund is available before medication is processed by the partner pharmacy, while another promotional page says a full refund is available before the prescription is written. Both say refunds are unavailable once the prescription is processed and sent to the pharmacy.

The practical takeaway is to request cancellation immediately and ask Sprout to identify which written policy controls the order. Save the checkout terms, cancellation request, portal confirmation, and any refund response. Canceling future service is not the same as obtaining a refund for a prescription charge.

Damaged, missing, or stolen shipments

Sprout’s public refund policy says damaged, lost, or unreceived medication should be reported within 48 hours. It asks for the order number, tracking number, and photographic evidence when applicable. The provider says it will assess the request and may issue a credit for a replacement order.

This is a shipment-issue process, not a general satisfaction refund.

Insurance and payment

Sprout says it does not require, accept, or bill insurance for the advertised compounded program. Public pages describe online payment by major credit or debit card.

Consumers should not assume that an HSA, FSA, insurance reimbursement, or out-of-network claim will be accepted unless they verify eligibility with the plan administrator and receive the documentation required for reimbursement.

Is the lowest Sprout Health price the best comparison number?

Not by itself. A useful comparison should include:

• Amount due today.
• Standard renewal amount.
• Medication and formulation.
• Number of months and shipments included.
• Clinician and refill services.
• Laboratory costs.
• Cancellation deadline.
• Refund cutoff.
• Pharmacy identity and state availability.

A lower introductory price may still produce a higher total if it renews at a different amount or requires a longer prepaid commitment.

Questions to ask before paying

1. Which medication and formulation does this checkout cover?
2. What is charged today, and what is the normal renewal amount?
3. Is this monthly, quarterly, or prepaid?
4. How many shipments and medication doses are included?
5. Are clinician visits, messaging, supplies, and shipping included?
6. Are laboratory tests required, and who pays?
7. Which pharmacy will fill the prescription?
8. What exact date must I cancel to prevent the next charge?
9. Which refund policy applies if the clinician has reviewed my intake but the prescription has not reached the pharmacy?
10. What happens to unshipped months if I cancel a prepaid plan?

Bottom line

Sprout Health’s main GLP-1 FAQ still lists $299 for compounded semaglutide and $349 for compounded tirzepatide, while its homepage and dedicated tirzepatide page now surface lower starting figures, including $199 for compounded tirzepatide. Three-month and first-cycle promotions add another layer.

The main cost risk is not a hidden membership fee. It is mistaking a starting or promotional number for the standard recurring price, plus the variation between funnels, recurring billing, quarterly fulfillment details, and inconsistent refund summaries. Compare the complete written checkout terms rather than the lowest headline price.

Review Sprout Health’s Current Checkout Terms

· Compare online GLP-1 programs

Affiliate disclosure: Care Path Compare may receive compensation if you use a Sprout Health link and make a purchase, at no extra cost to you. Compensation does not determine our editorial conclusions.